Pitfalls in 18F-FDG PET/CT in Malignant Lymphoma.

Prostate Cancer-Specific Positron Emission Tomography with Different Radiotracers.

How Hybrid PET/CT Improve Pitfalls and Artifacts in Malignant Lymphoma?

Added Value of 68Gallium-PSMA PET/CT Over Contrast Enhanced CT in Prostate Cancer Patients

Diagnostic Value of 18F labeled PSMA PET/CT Imaging in Biochemical recurrence of Prostate Cancer after Curative Therapy

Impact of 18F-FDG PET/CT Dual Time Point Imaging in Lymphoma Patients with Lung Lesions.

Diagnostic Accuracy of Surveillance of FDG-PET/CT in Detection of Early Relapse in Malignant Lymphoma.

Prognostic Value of Volume Based Parameters of PET/CT in Malignant Lymphoma.

PET/CT Dual Time Point Scanning in Evaluation of Malignant Lymphoma

Theranostics in Prostate Cancer.